112 related articles for article (PubMed ID: 30797871)
1. New options of cancer treatment employing InsP
Brehm MA; Windhorst S
Biochem Pharmacol; 2019 May; 163():206-214. PubMed ID: 30797871
[TBL] [Abstract][Full Text] [Related]
2. Intracellular and extracellular myo-inositol hexakisphosphate (InsP6), from rats to humans.
Grases F; Costa-Bauza A; Prieto RM
Anticancer Res; 2005; 25(3c):2593-7. PubMed ID: 16080499
[TBL] [Abstract][Full Text] [Related]
3. IP6-induced growth inhibition and differentiation of HT-29 human colon cancer cells: involvement of intracellular inositol phosphates.
Yang GY; Shamsuddin AM
Anticancer Res; 1995; 15(6B):2479-87. PubMed ID: 8669811
[TBL] [Abstract][Full Text] [Related]
4. Inositol Hexaphosphate Inhibits Proliferation and Induces Apoptosis of Colon Cancer Cells by Suppressing the AKT/mTOR Signaling Pathway.
Kapral M; Wawszczyk J; Jesse K; Paul-Samojedny M; Kuśmierz D; Węglarz L
Molecules; 2017 Oct; 22(10):. PubMed ID: 28972559
[No Abstract] [Full Text] [Related]
5. Inositol phosphates have novel anticancer function.
Shamsuddin AM
J Nutr; 1995 Mar; 125(3 Suppl):725S-732S. PubMed ID: 7884558
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibition and differentiation of HT-29 cells in vitro by inositol hexaphosphate (phytic acid).
Sakamoto K; Venkatraman G; Shamsuddin AM
Carcinogenesis; 1993 Sep; 14(9):1815-9. PubMed ID: 7691427
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic effect of inositol hexaphosphate and its Ni(II) complex on human acute leukemia Jurkat T cells.
de Lima EM; Kanunfre CC; de Andrade LF; Granato D; Rosso ND
Toxicol In Vitro; 2015 Dec; 29(8):2081-8. PubMed ID: 26335902
[TBL] [Abstract][Full Text] [Related]
8. Malignant H1299 tumour cells preferentially internalize iron-bound inositol hexakisphosphate.
Helmis C; Blechner C; Lin H; Schweizer M; Mayr GW; Nielsen P; Windhorst S
Biosci Rep; 2013 Oct; 33(5):. PubMed ID: 24050387
[TBL] [Abstract][Full Text] [Related]
9. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin: study of the matrix effects. mechanism of phytate topical absorption.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM
Front Biosci; 2005 Jan; 10():799-802. PubMed ID: 15569619
[TBL] [Abstract][Full Text] [Related]
10. The intracellular distribution of inositol polyphosphates in HL60 promyeloid cells.
Stuart JA; Anderson KL; French PJ; Kirk CJ; Michell RH
Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):517-25. PubMed ID: 7980412
[TBL] [Abstract][Full Text] [Related]
11. Inositol hexaphosphate (InsP6) as an effective topical treatment for patients receiving adjuvant chemotherapy after breast surgery.
Proietti S; Pasta V; Cucina A; Aragona C; Palombi E; Vucenik I; Bizzarri M
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(2 Suppl):43-50. PubMed ID: 28724186
[TBL] [Abstract][Full Text] [Related]
12. Characterization of inositol hexakisphosphate (InsP6)-mediated priming in human neutrophils: lack of extracellular [3H]-InsP6 receptors.
Kitchen E; Condliffe AM; Rossi AG; Haslett C; Chilvers ER
Br J Pharmacol; 1996 Mar; 117(5):979-85. PubMed ID: 8851521
[TBL] [Abstract][Full Text] [Related]
13. Discovery of InsP6-kinases as InsP6-dephosphorylating enzymes provides a new mechanism of cytosolic InsP6 degradation driven by the cellular ATP/ADP ratio.
Wundenberg T; Grabinski N; Lin H; Mayr GW
Biochem J; 2014 Aug; 462(1):173-84. PubMed ID: 24865181
[TBL] [Abstract][Full Text] [Related]
14. Inositol hexakisphosphate in urine: the relationship between oral intake and urinary excretion.
Grases F; Simonet BM; March JG; Prieto RM
BJU Int; 2000 Jan; 85(1):138-42. PubMed ID: 10619962
[TBL] [Abstract][Full Text] [Related]
15. Inositol hexakisphosphate binding sites in rat heart and brain.
Rowley KG; Gundlach AL; Cincotta M; Louis WJ
Br J Pharmacol; 1996 Aug; 118(7):1615-20. PubMed ID: 8842422
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of iron-catalysed hydroxyl radical formation by inositol polyphosphates: a possible physiological function for myo-inositol hexakisphosphate.
Hawkins PT; Poyner DR; Jackson TR; Letcher AJ; Lander DA; Irvine RF
Biochem J; 1993 Sep; 294 ( Pt 3)(Pt 3):929-34. PubMed ID: 8379947
[TBL] [Abstract][Full Text] [Related]
17. Inositol hexakisphosphate and beta-cell stimulus-secretion coupling.
Barker CJ; Berggren PO
Anticancer Res; 1999; 19(5A):3737-41. PubMed ID: 10625950
[TBL] [Abstract][Full Text] [Related]
18. Characterization of myo-inositol hexakisphosphate deposits from larval Echinococcus granulosus.
Casaravilla C; Brearley C; Soulé S; Fontana C; Veiga N; Bessio MI; Ferreira F; Kremer C; Díaz A
FEBS J; 2006 Jul; 273(14):3192-203. PubMed ID: 16792701
[TBL] [Abstract][Full Text] [Related]
19. Novel anti-cancer functions of IP6: growth inhibition and differentiation of human mammary cancer cell lines in vitro.
Shamsuddin AM; Yang GY; Vucenik I
Anticancer Res; 1996; 16(6A):3287-92. PubMed ID: 9042302
[TBL] [Abstract][Full Text] [Related]
20. Absorption of myo-inositol hexakisphosphate (InsP6) through the skin in humans.
Grases F; Isern B; Perelló J; Sanchis P; Prieto RM; Costa-Bauzà A
Pharmazie; 2006 Jul; 61(7):652. PubMed ID: 16889078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
